Home
>
National Drug Code (NDC)
>
Zarontin
Zarontin - 0071-0237-24 - (Ethosuximide)
Drug Information of Zarontin
| Product NDC: | 0071-0237 |
| Proprietary Name: | Zarontin |
| Non Proprietary Name: | Ethosuximide |
| Active Ingredient(s): | 250 mg/1 & nbsp; Ethosuximide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zarontin
| Product NDC: | 0071-0237 |
| Labeler Name: | Parke-Davis Div of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012380 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000922 |
Package Information of Zarontin
| Package NDC: | 0071-0237-24 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0071-0237-24) |
NDC Information of Zarontin
| NDC Code | 0071-0237-24 |
| Proprietary Name | Zarontin |
| Package Description | 100 CAPSULE in 1 BOTTLE (0071-0237-24) |
| Product NDC | 0071-0237 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ethosuximide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20000922 |
| Marketing Category Name | NDA |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | ETHOSUXIMIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
